David Elashoff

5.6k total citations · 1 hit paper
88 papers, 4.1k citations indexed

About

David Elashoff is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, David Elashoff has authored 88 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 17 papers in Surgery and 17 papers in Molecular Biology. Recurrent topics in David Elashoff's work include Salivary Gland Disorders and Functions (8 papers), Head and Neck Cancer Studies (7 papers) and Cancer-related molecular mechanisms research (7 papers). David Elashoff is often cited by papers focused on Salivary Gland Disorders and Functions (8 papers), Head and Neck Cancer Studies (7 papers) and Cancer-related molecular mechanisms research (7 papers). David Elashoff collaborates with scholars based in United States, Germany and United Kingdom. David Elashoff's co-authors include David T. Wong, Jianghua Wang, Elliot Abemayor, Shen Hu, Joseph A. Loo, Uttam K. Sinha, Xiaofeng Zhou, Maie A.R. St. John, David Chia and James J. Farrell and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

David Elashoff

85 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer

2011 502 citations James J. Farrell, Lei Zhang et al. Gut profile →

Peers

Countries citing papers authored by David Elashoff

Since Specialization

Citations

This map shows the geographic impact of David Elashoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Elashoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Elashoff more than expected).

Fields of papers citing papers by David Elashoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Elashoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Elashoff. The network helps show where David Elashoff may publish in the future.

Co-authorship network of co-authors of David Elashoff

This figure shows the co-authorship network connecting the top 25 collaborators of David Elashoff. A scholar is included among the top collaborators of David Elashoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Elashoff. David Elashoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improved Survival of Advanced‐Stage Anaplastic Thyroid Cancer With Systemic Therapy 2024 ·The Laryngoscope ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), David Elashoff, Wanxing Chai‐Ho, Deborah J. Wong, Maie A. St. John	3
2	Salivary inflammatory biomarkers as a predictor of post-traumatic stress disorder and depressive symptom severity in trauma patients: A prospective study 2024 ·Brain Behavior and Immunity ·Theodore F. Robles, Dennis Rünger, Jennifer A. Sumner, David Elashoff, Vivek Shetty	3
3	Consent document translation expense hinders inclusive clinical trial enrolment 2023 ·Nature ·Maria A. Velez, Beth A. Glenn, (unknown), Amy L. Cummings, Aaron Lisberg, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jenny Brook, Tristan Grogan, David Elashoff, Michael A. Teitell, Edward B. Garon	11
4	Warning symptoms associated with imminent sudden cardiac arrest: a population-based case-control study with external validation 2023 ·The Lancet Digital Health ·Kyndaron Reinier, (unknown), Harpriya Chugh, (unknown), (unknown), (unknown), Audrey Uy‐Evanado, Faye L. Norby, Kotoka Nakamura, (unknown), (unknown), Tristan Grogan, David Elashoff, Jonathan Jui, Angelo Salvucci, Sumeet S. Chugh	10
5	Performance of Salivary Extracellular RNA Biomarker Panels for Gastric Cancer Differs between Distinct Populations 2022 ·Cancers ·Karolina Elżbieta Kaczor‐Urbanowicz, (unknown), Tristan Grogan, Feng Li, You Jeong Heo, David Elashoff, Robert S. Bresalier, David T. Wong, Yong Kim	7
6	Proficiency Testing of Epidermal Growth Factor Receptor Mutations Detection in Saliva Using Spectrum Saliva Collector (SDNA-1000) and Preservative Solution Detected by Electric Field-Induced Release and Measurement 2022 ·Biopreservation and Biobanking ·Feng Li, (unknown), Tristan Grogan, David Elashoff, David M. Vu, David J Vigerust, (unknown), David T. Wong	1
7	Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non–Small Cell Lung Cancer 2019 ·Clinical Cancer Research ·Siwen Hu‐Lieskovan, Aaron Lisberg, Jesse M. Zaretsky, Tristan Grogan, Hira Rizvi, Daniel K. Wells, James Carroll, Amy L. Cummings, John Madrigal, Benjamin Jones, Jaklin Gukasyan, I. Peter Shintaku, Dennis J. Slamon, Steven M. Dubinett, Jonathan W. Goldman, David Elashoff, Matthew D. Hellmann, Antoni Ribas, Edward B. Garon	56
8	Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection 2017 ·Cancer Prevention Research ·Ana B. Pavel, Joshua D. Campbell, Gang Liu, David Elashoff, Steven M. Dubinett, Kate Smith, Duncan Whitney, Marc E. Lenburg, Avrum Spira	36
9	Salivary extracellular RNA biomarkers for insulin resistance detection in hispanics 2017 ·Diabetes Research and Clinical Practice ·Yong Zhang, Jie Sun, Feng Li, Tristan Grogan, (unknown), Qingxian Luan, (unknown), David Chia, David Elashoff, Kaumudi Joshipura, David T. Wong	6
10	Effect of Brain Amyloidosis on the Emergence of Neuropsychiatric Behaviors in MCI over Time (P2.232) 2016 ·Neurology ·Liana G. Apostolova, Naira Goukasian, (unknown), Jonathan Grotts, John M. Ringman, David Elashoff	2
11	Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas 2014 ·Journal of Thoracic and Cardiovascular Surgery ·Tony Lin, (unknown), Jane Yanagawa, (unknown), Gerald Wang, (unknown), David Elashoff, Tristan Grogan, Robert B. Cameron, Arun S. Singh, Bartosz Chmielowski, Noah Federman, Scott D. Nelson, Percy Lee, Fritz C. Eilber, Jay M. Lee	46
12	Head and neck sarcomas: the UCLA experience 2014 ·American Journal of Otolaryngology ·Bobby A. Tajudeen, Jennifer C. Fuller, Chi Lai, Tristan Grogan, David Elashoff, Elliot Abemayor, Maie A. St. John	27
13	Correlation of a Novel Noninvasive Tissue Oxygen Saturation Monitor to Serum Central Venous Oxygen Saturation in Pediatric Patients with Postoperative Congenital Cyanotic Heart Disease 2013 ·Journal of ExtraCorporeal Technology ·(unknown), Tristan Grogan, David Elashoff, Robert B. Kelly	4
14	Lung Cancer Chemoprevention with Celecoxib in Former Smokers 2011 ·Cancer Prevention Research ·Jenny T. Mao, Michael D. Roth, Michael C. Fishbein, Denise R. Aberle, Zuo‐Feng Zhang, Jian Rao, Donald P. Tashkin, Lee Goodglick, E. Carmack Holmes, Robert B. Cameron, Steven M. Dubinett, Robert M. Elashoff, Éva Szabó, David Elashoff	65
15	Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer breakdown → 2011 ·Gut ·James J. Farrell, Lei Zhang, Hui Zhou, David Chia, David Elashoff, David Akin, Bruce J. Paster, Kaumudi Joshipura, David T. Wong	502
16	Lung Cancer Biomarkers: FISHing in the Sputum for Risk Assessment and Early Detection 2010 ·Cancer Prevention Research ·Brigitte N. Gomperts, Avrum Spira, David Elashoff, Steven M. Dubinett	6
17	Identification of Common Predictive Markers of In vitro Response to the Mek Inhibitor Selumetinib (AZD6244; ARRY-142886) in Human Breast Cancer and Non–Small Cell Lung Cancer Cell Lines 2010 ·Molecular Cancer Therapeutics ·Edward B. Garon, Richard S. Finn, Wylie Hosmer, Judy Dering, Charles Ginther, (unknown), Naeimeh Kamranpour, Sharon Pitts, Amrita Desai, David Elashoff, Tim French, Paul D. Smith, Dennis J. Slamon	49
18	Occupational Medicine Practice: One Specialty or Three? 2010 ·Journal of Occupational and Environmental Medicine ·Philip Harber, (unknown), (unknown), (unknown), Yihang Liu, David Elashoff, (unknown)	16
19	Salivary Proteomics for Oral Cancer Biomarker Discovery 2008 ·Clinical Cancer Research ·Shen Hu, Martha Arellano, Pinmanee Boontheung, Jianghua Wang, Hui Zhou, Jiang Jiang, David Elashoff, Roger Wei, Joseph A. Loo, David T. Wong	425
20	Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins 2006 ·Gut ·(unknown), Howard A. Reber, Sarah Dry, David Elashoff, (unknown), Naoyuki Umetani, Minoru Kitago, O. Joe Hines, Kevork Kazanjian, Sumie Hiramatsu, Anton J. Bilchik, Suk Joong Yong, Margo Shoup, Dave S.�B. Hoon	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact